AGX816

SARS-CoV-2 Spike (RBD, aa 331-524) Recombinant Antigen

suitable for ELISA, suitable for immunodiffusion

• Synonym(e): 2019-nCoV, COVID-19
• UNSPSC-Code: 51201600
• NACRES: NA.26

Eigenschaften

• Rekombinant: expressed in HEK 293 cells
• Qualitätsniveau: 100
• Form: liquid
• Lagerbedingungen: avoid repeated freeze/thaw cycles
• Methode(n): ELISA: suitable; immunodiffusion: suitable; lateral flow assay: suitable
• Versandbedingung: dry ice

Beschreibung

Allgemeine Beschreibung

COVID-19 Spike (RBD, aa 331-524) Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX816 is for use in ELISA, and Lateral Flow Assay as Positive Control.

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleoprotein antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

Physikalische Form

Purified protein in 10mM Phosphate Buffered Saline without preservatives, pH 7.0.

Angaben zur Herstellung

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Stable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sicherheitshinweise

• Lagerklassenschlüssel: 12 - Non Combustible Liquids
• WGK: WGK 2
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable